Loading…
Briacell Therapeutics Corp Is A Clinical-Stage Biotechnology Company Focused On Developing Immunotherapies For Cancer Treatment, Particularly Breast Cancer. The Company'S Targeted Immunotherapy Program, Bria-Imt, Is A Targeted Cell-Based Immunotherapy In End-Stage Clinical Trials Aiming To Improve Outcomes For Patients With Breast Cancer. Briacell Also Develops Bria-Ots, Personalized Off-The-Shelf Immunotherapies For Breast And Prostate Cancer. Briacell Is Involved In Clinical Collaborations To Explore Combination Therapies For Enhanced Cancer Treatment Options.